These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19621005)

  • 41. [What attitude to adopt towards the coronary stents?].
    Albaladejo P
    Ann Fr Anesth Reanim; 2007 Dec; 26(12):1108-10. PubMed ID: 18273447
    [No Abstract]   [Full Text] [Related]  

  • 42. Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?
    Azarbal B; Currier JW
    J Am Coll Cardiol; 2006 Jan; 47(1):182-3. PubMed ID: 16386684
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antiplatelet therapy after the drug-eluting stent placement].
    Hashimoto T; Ako J
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():384-8. PubMed ID: 27534200
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug-eluting coronary stents: hypersensitivity reactions to paclitaxel and the risk of Kounis syndrome.
    Soufras GD; Kounis GN; Chiladakis JA; Kounis SA; Gouvelou-Deligianni GV; Batsolaki M; Kounis NG
    Dermatology; 2009; 219(1):87-8. PubMed ID: 19246881
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evidence-based science/ the effect of paclitaxel-eluting stents on restenosis].
    Alat I
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):200-1; author reply 201-2. PubMed ID: 16766297
    [No Abstract]   [Full Text] [Related]  

  • 46. Will we ever know the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation?
    Kastrati A; Byrne RA; Schulz S
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1129-32. PubMed ID: 22017939
    [No Abstract]   [Full Text] [Related]  

  • 47. Paclitaxel versus sirolimus: the battle is still ongoing.
    Stefanadis C; Toutouzas K
    J Am Coll Cardiol; 2009 Feb; 53(8):665-6. PubMed ID: 19232898
    [No Abstract]   [Full Text] [Related]  

  • 48. Late in-stent restenosis in a patient with drug-eluting stent.
    Sultan FA; Kazmi K; Dhakam S; Quraishi AU
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Everolimus-eluting versus paclitaxel-eluting stents.
    Kounis NG; Goudevenos JA
    Lancet; 2010 Apr; 375(9721):1161; author reply 1161-2. PubMed ID: 20362810
    [No Abstract]   [Full Text] [Related]  

  • 50. [Drug-eluting stents: long-term safety].
    Karpov IuA; Samko AN; Buza VV
    Ter Arkh; 2009; 81(5):36-41. PubMed ID: 19537584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A shift in the use of drug-eluting stents in Australian private hospitals.
    McLean SM; Clark DJ
    Med J Aust; 2008 Jan; 188(2):127. PubMed ID: 18205596
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug-eluting stent for long coronary artery disease.
    Park SJ; Kim YH
    Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
    [No Abstract]   [Full Text] [Related]  

  • 54. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the endeavor zotarolimus-eluting coronary stent.
    Pinto Slottow TL; Waksman R
    Circulation; 2008 Mar; 117(12):1603-8. PubMed ID: 18362244
    [No Abstract]   [Full Text] [Related]  

  • 55. The high cost of nonadherence after percutaneous coronary intervention--can health care reform solve this problem?
    Mukherjee D
    Am Heart J; 2009 Oct; 158(4):506-8. PubMed ID: 19781406
    [No Abstract]   [Full Text] [Related]  

  • 56. Tirofiban 'bridging' therapy for patients with drug-eluting stents undergoing non-cardiac surgery.
    Bolsin S; Conroy M; Osborne C
    Br J Anaesth; 2010 Jun; 104(6):779; author reply 779-80. PubMed ID: 20460570
    [No Abstract]   [Full Text] [Related]  

  • 57. [Drug-eluting stents - new standard of restenosis treatment].
    Koziński M; Kubica J
    Kardiol Pol; 2009 May; 67(5):539-49. PubMed ID: 19521942
    [No Abstract]   [Full Text] [Related]  

  • 58. Stent thrombosis and Kounis syndrome: who is guilty?
    Kounis NG; Almpanis G; Mazarakis A
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):71-2. PubMed ID: 20671574
    [No Abstract]   [Full Text] [Related]  

  • 59. Definition, incidence, correlates, and clinical impact of "nuisance" bleeding in patients undergoing drug-eluting stent implantation.
    Waksman R
    Am J Cardiol; 2009 Sep; 104(5 Suppl):30C-3C. PubMed ID: 19695358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevention and treatment of thrombosis after implantation of drug-eluting stents].
    Han YL
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1516-7. PubMed ID: 17785098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.